Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus

Antimicrob Agents Chemother. 1998 Aug;42(8):2122-4. doi: 10.1128/AAC.42.8.2122.

Abstract

A total of 201 Staphylococcus aureus isolates were surveyed for susceptibility to ciprofloxacin and trovafloxacin. Of 66 methicillin-resistant isolates, 89% were ciprofloxacin resistant and 6% were also trovafloxacin resistant. Trovafloxacin-resistant strains had unusual patterns of quinoline resistance mutations in DNA topoisomerase genes, including two mutations in the A subunit (encoded by grlA) of topoisomerase IV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Ciprofloxacin / pharmacology
  • DNA Topoisomerase IV
  • DNA Topoisomerases, Type II / genetics*
  • Drug Resistance, Microbial
  • Fluoroquinolones*
  • Humans
  • Microbial Sensitivity Tests
  • Mutation*
  • Naphthyridines / pharmacology*
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / enzymology*

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Naphthyridines
  • Ciprofloxacin
  • trovafloxacin
  • DNA Topoisomerase IV
  • DNA Topoisomerases, Type II

Associated data

  • GENBANK/AF044066
  • GENBANK/AF044067
  • GENBANK/AF044068
  • GENBANK/AF044069
  • GENBANK/AF044070
  • GENBANK/AF044071
  • GENBANK/AF044072
  • GENBANK/AF044073
  • GENBANK/AF044074
  • GENBANK/AF044075
  • GENBANK/AF044897
  • GENBANK/AF044898
  • GENBANK/AF044899
  • GENBANK/AF044900
  • GENBANK/AF044901
  • GENBANK/AF044902
  • GENBANK/AF044903
  • GENBANK/AF044904
  • GENBANK/AF044905
  • GENBANK/AF044906